Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Interest & Investment Income: 2016-2017

Historic Interest & Investment Income for Aytu Biopharma (AYTU) over the last 2 years, with Jun 2017 value amounting to -$2.4 million.

  • Aytu Biopharma's Interest & Investment Income rose 21.05% to -$425,425 in Q1 2021 from the same period last year, while for Mar 2021 it was -$1.9 million, marking a year-over-year change of. This contributed to the annual value of -$2.4 million for FY2017, which is 63.20% up from last year.
  • Aytu Biopharma's Interest & Investment Income amounted to -$2.4 million in FY2017, which was up 63.20% from -$6.5 million recorded in FY2016.
  • Aytu Biopharma's Interest & Investment Income's 5-year high stood at -$2.4 million during FY2017, with a 5-year trough of -$6.5 million in FY2016.
  • For the 2-year period, Aytu Biopharma's Interest & Investment Income averaged around -$4.4 million, with its median value being -$4.4 million (2016).
  • Data for Aytu Biopharma's Interest & Investment Income shows a peak YoY soared of 63.20% (in 2017) over the last 5 years.
  • Aytu Biopharma's Interest & Investment Income (Yearly) stood at -$6.5 million in 2016, then skyrocketed by 63.20% to -$2.4 million in 2017.